Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Seattle Genetics' Controversial Collaboration With Immunomedics Topples

DealWatch_1200x675

Related Content

Conatus' Liver Focus Goes Well Beyond NASH

Nov 30 2015

Akebia Strikes $350m+ Asian Vadadustat Alliance

Dec 15 2015

Sosei Backs RNA Activation Through Sizeable Equity And Option Deal

May 03 2017

AstraZeneca Taps Pieris For Inhaled Asthma Anticalins

May 03 2017

With Parion Deal Done, Shire CEO Looks To Next Bright Ophthalmic Innovation

May 02 2017

Sanofi Scouting For Cancer Deals, Diabetes Drugs Miss In 1Q

Apr 28 2017

TaiGen Biotech Eyes Pneumonia Antibiotic On China's Market By Year End

Apr 30 2014

Transgene’s Moment Of Truth Approaches

Dec 07 2016

In Novartis, Conatus Lands Experienced, Deep-Pocketed NASH Partner

Dec 20 2016

Akebia Holds Development Reins In Anemia While Otsuka Jumps On Vadadustat Sleigh

Dec 22 2016

Deal Watch: Seattle Genetics Adds To Antibody-Drug Conjugate Portfolio

Feb 14 2017

Related Companies

Seagen Inc.

Immunomedics, Inc.

Novartis AG

Conatus Pharmaceuticals Inc.

Pfizer Inc.

Conatus Pharmaceuticals Inc.

Celyad Oncology SA

Ono Pharmaceutical Company, Ltd.

University of Pennsylvania

Parion Sciences, Inc.

Takeda Pharmaceutical Co. Ltd.

Santen Pharmaceutical Co., Ltd.

Paratek Pharmaceuticals, Inc.

Zai Lab Ltd.

Zhejiang Medicine Co., Ltd

TaiGen Biotechnology Co., Ltd.

Yungjin Pharmaceutical Co. Ltd.

Abliva AB

Akebia Therapeutics, Inc.

Otsuka Holdings Co., Ltd.

Mitsubishi Tanabe Pharma Corporation

Transgene S.A.

bioMerieux SA

Bristol Myers Squibb Company

Aurigene Oncology

Agios Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Xenon Pharmaceuticals, Inc.

1st Order Pharmaceuticals, Inc.

Bausch Health Companies Inc.

Akorn, Inc.

Fresenius SE & Co. KGaA

Merck KGaA

Fresenius SE & Co. KGaA

Becton, Dickinson and Company

AstraZeneca PLC

Pieris Pharmaceuticals, Inc.

MiNA Therapeutics Limited

Nxera Pharma Co., Ltd.

Additional Topics

Deals M & A Business Strategies BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window